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INTRODUCTION:
Hematopoietic stem cells isolated from peripheral blood can be used to reconstitute patients with bone marrow failure, and stem cells from peripheral blood have been recommended for hematopoietic engraftment. [1] [2] [3] [4] Autologous peripheral blood has been used to repopulate bone marrow in cancer patients [5] [6] [7] [8] [9] [10] , and patients with chronic myelogenous leukemia have been treated with autologous cryopreserved leukocytes. [11] [12] [13] In studies performed at the Naval Blood Research Laboratory, mononuclear cells from human peripheral blood have been frozen, thawed, and washed, with in vitro recovery values of 80%. 14 The Naval Blood Research Laboratory has studied the effects of temperature and length of frozen storage and of the freezing container on PBMC isolated from plateletpheresis residues by a ficoll-hypaque procedure [14] [15] . Comparisons were made of PBMC frozen and stored in polyethylene provials at -80 C, -135 C, -150 C, and -197 C and in
Polyvinylchloride plastic bags at -80 C and -135 C for as long as 2.4
years. Measurements were made of freeze-thaw-wash in vitro recovery and membrane integrity. 16 Pluripotential stem cell activity has been assessed in fresh and cryopreserved PBMC using the CFU-GEMM assay [17] [18] . 
OBJECTIVE:

METHODS:
Isolation of Peripheral Blood Mononuclear cells
The mononuclear cells were isolated from the plateletpheresis residue by the Ficoll-Hypaque density (1.077 g/ml) gradient centrifugation procedure using a plastic bag system (Ethox Corp) [14] [15] .
The cells were washed once with 0.9% sodium chloride and were resuspended in approximately 85 ml autologous plasma.
Cryopreservation of Mononuclear Cells
The PBMC suspension was separated into aliquots which were frozen and stored in 10% DMSO and autologous plasma as follows: Measurements were made of in vitro recovery and viability, and the recovery/viability index calculated as recovery X viability/100. CFU-GEMM assays were done to measure pluripotential stem cell activity.
In Vitro Viability Testing
The mononuclear cells were incubated with a fluoroscein diacetate and ethidium bromide mixture followed by fluorescence microscopy to evaluate membrane integrity 16 .
In Vitro Assay for Hematopoietic Stem Cells (CFU-GEMM)
Two CFU-GEMM assays were employed. In the first, underlays containing human leukocytes were used. In the second, underlays without leukocytes were used and the cells were cultured in the presence of medium conditioned by leukocytes stimulated with phytohemagglutinin (PHA-LCM). Mononuclear cell preparations in a semi-solid methycellulose medium were cultured on each of the two agar-based support underlays according to a modification of the method of Ash et al [17] [18] .
The mononuclear cells were counted using phase microscopy, diluted with enriched ImDm-30% FBS and added to the 1.5% MC in ImDm-FBS. The final culture medium contained a known number of mononuclear cells, 1% MC in ImDm with 30% FBS, 5 X 10" 5 M ME, and 1 unit of EP and 1 unit of heparin per ml in a total volume of 2.5 ml. Two 0.5 ml aliquots were plated into two wells of previously prepared underlays which contained 1 X 10 6 /ml human leukocytes. Two additional 0.5 ml aliquots together with two 0.025 ml aliquots of PHA-LCM (final concentration of 5%) were plated on underlays containing no leukocytes. Aliquots containing 50, 70 and 100 x 10 5 PBMC were plated.
Clusters of 40 or more unfixed and unstained cells, observed by a stereoscopic microscope at 20-50X, were scored as colonies.
Colonies with a reddish-white appearance were scored as mixed colonies (CFU-GEMM) containing erythroid and one or more of the following cell lines: granulocytes, monocytes, macrophages, and megakarocytes 17 ' 18 .
The numbers of CFU-GEMM at 50, 75 and 100 x 10 5 plating concentrations were recorded. The colonies were plotted against the plating concentration to assure a linear dose response, and the number of CFU-GEMM per 100 x 10 5 PBMC was determined from linear regression and reported.
RESULTS:
In vitro recovery and viability Tables 1 and 2 Peripheral blood mononuclear cells cryopreserved in provials at -80 C for 1.5 years showed a reduction in hematopoietic activity which was related to the -80 C storage temperature: CFU-GEMM activity after thawing and washing was significantly reduced than that seen in PBMC frozen and stored at -135 C, -150 C, and -197 C. After 2.4 years of frozen storage at -80 C, a similar reduction was observed.
The mean PBMC in vitro freeze-thaw-wash recovery value after storage in plastic bags at -80 C and -135 C for as long as 2.4 years was greater than 90%, and the mean viability value was greater than 94%, significantly higher than the PBMC stored in provials.
The mean freeze-thaw-wash recovery values of PBMC frozen in provials at -80 C or -135 C and stored for 1.5 years and 2.4 years were less than 75%.
The viability values were also slightly but not significantly lower in the PBMC frozen and stored in provials than in those stored in plastic bags.
PBMC stored frozen in plastic bags for 1. 
